Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Ewa, Brojer"'
Autor:
Marzena Dębska, Małgorzata Uhrynowska, Katarzyna Guz, Izabella Kopeć, Elżbieta Lachert, Agnieszka Orzińska, Piotr Kretowicz, Jolanta Antoniewicz-Papis, Romuald Dębski, Magdalena Łętowska, Anne Husebekk, Ewa Brojer
Publikováno v:
Archives of Medical Science, Vol 14, Iss 5, Pp 1041-1047 (2016)
Introduction : Pregnant women negative for human platelet antigen 1 a (HPA-1a) are at risk of alloimmunization with fetal HPA-1a antigen inherited from the father, and their offspring may develop fetal and neonatal alloimmune thrombocytopenia (FNAIT)
Externí odkaz:
https://doaj.org/article/4584c56eca31439fb15b493379270a80
Autor:
Radoslaw Kaczmarek, Katarzyna Szymczak-Kulus, Anna Bereźnicka, Krzysztof Mikołajczyk, Maria Duk, Edyta Majorczyk, Anna Krop-Watorek, Elżbieta Klausa, Joanna Skowrońska, Bogumiła Michalewska, Ewa Brojer, Marcin Czerwinski
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0196627 (2018)
Contrary to the mainstream blood group systems, P1PK continues to puzzle and generate controversies over its molecular background. The P1PK system comprises three glycosphingolipid antigens: Pk, P1 and NOR, all synthesised by a glycosyltransferase ca
Externí odkaz:
https://doaj.org/article/bae28e40d27b4a48b18a75757c13b849
Autor:
Ryszard Pogłód, Agnieszka Gierszon, Agata Mikołowska, Magdalena Łętowska, Zbigniew M. Szczepiorkowski, Piotr Grabarczyk, Aleksandra Kalińska, Agnieszka Orzińska, Aleksandra Rosiek, Monika Pelc-Kłopotowska, Jolanta Korsak, Ewa Brojer, Bogumiła Michalewska, Jacek Nowak, Adam Olszewski, Beata Uszyńska-Kałuża, P. Łopacz, Ewa Sulkowska, Piotr Radziwon, Aneta Kopacz, Małgorzata Uhrynowska, Jadwiga Fabijańska-Mitek, Katarzyna Guz, Elżbieta Lachert, Anna Stachurska-Skrodzka, Beata Wojciechowska, Jolanta Antoniewicz-Papis
Publikováno v:
National Information Processing Institute
Transfusion of blood and blood components is one of the widely used medical procedures. The responsibility for provision of blood and blood components lies with Polish blood transfusion centers (CKiK) substantively supervised by the Institute of Hema
Autor:
Magdalena Łętowska, Ewa Brojer, Monika Pelc-Kłopotowska, Agnieszka Orzińska, Katarzyna Guz, Bogumiła Michalewska
Publikováno v:
Journal of Transfusion Medicine. 12:199-205
The aim of the study is to present current applications of molecular biology methods in immunohematology as well as the status of their implementation in the Polish Blood Transfusion Service. Molecular biology methods are used for: analysis of molecu
Autor:
Joanna Skulimowska, Edyta Klimczak-Jajor, Ewa Brojer, Marzena Dębska, Katarzyna Guz, Paweł Turowski
Publikováno v:
Acta Haematologica Polonica. 50:226-231
StreszczenieTalasemia alfa to niedokrwistość wynikająca z mutacji w genach kodujących alfa-globinę lub w elementach regulatorowych klastra alfa-globiny. Zespół hemoglobiny Barta to najcięższa postać tej niedokrwistości, spowodowana defekte
Publikováno v:
Journal of Transfusion Medicine. 12:56-64
In recent years, we have been observing the rapid development of molecular research technologies used in immunohematology. They are currently used not only by reference and highly specialized laboratories, but also for massive examinations in blood c
Autor:
Magdalena Łętowska, Ewa Brojer
Publikováno v:
Journal of Transfusion Medicine. 12:72-76
Publikováno v:
International Journal of Clinical Transfusion Medicine. 7:11-22
Autor:
Agnieszka Gierszon, P. Łopacz, Małgorzata Uhrynowska, Agnieszka Orzińska, Ewa Brojer, Katarzyna Guz, K. Maślanka
Publikováno v:
Journal of Transfusion Medicine. 12:1-12
Clinical efficacy of PC transfusions in patients immunized with Human Leukocyte Antigens (HLA) and/or Human Platelet Antigens (HPA) can be improved by relying on platelets from donors typed for HPA and/or HLA. A specific group of PC recipients are ne
Autor:
Joanna Skulimowska, Małgorzata Uhrynowska, Edyta Klimczak-Jajor, Anna Ejduk, Katarzyna Guz, Ewa Brojer
Publikováno v:
Acta Haematologica Polonica. 50:21-24
BackgroundThis report presents a case of an adult Polish women of Caucasian origin who was heterozygous for the nondeletional mutation: Hb Handsworth (HBA2 or HBA1: c.55G > C, p.Gly19Arg) and deletional (-α3.7) α-thalassemia mutation.MethodsThe HbA